Phathom Pharmaceuticals is a biopharmaceutical company focused on transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights to vonoprazan, a novel potassium-competitive acid blocker, in the U.S., Europe, and Canada, Phathom aims to change the landscape of acid-related disorders while advancing a pipeline of innovative treatments for conditions like Eosinophilic Esophagitis.
No jobs found. Subscribe below to get notified when we find something for you.
Searching
Companies
Want job alerts that match your preferences?
Set up job preferences →